Dr. Elias on Androgen Receptor Inhibitors in HER2-Positive Breast Cancer
August 4th 2015
Anthony D. Elias, MD, professor, Division of Medical Oncology, University of Colorado School of Medicine, discusses using androgen receptor inhibitors as a potential treatment of patients with HER2-positive breast cancer.